Notice of Analyst and Investment Presentation - How to Register

Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines for approval by global regulatory agencies and targeting the US$ multi-billion pain market, intends to announce results for the half year ended 30 November 2021 on Tuesday 22 February 2022.

Analyst Briefing, 9:30 a.m., Tuesday 22 February 2022

A briefing for Analysts will be held at 9:30 a.m. GMT on the day of the results.

Analysts interested in attending should contact Walbrook PR by emailing oxcantech@walbrookpr.com or by calling 020 7933 8780.

Investor Presentation, 4:30 p.m., Tuesday 22 February 2022

A live online presentation via the Investor Meet Company platform will also be held at 4:30 p.m. GMT on Tuesday 22 February 2022, which is open to all existing and potential shareholders.

Questions can be submitted pre-event via the 'Investor Meet Company' dashboard up until 9:00 a.m. the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Oxford Cannabinoid Technologies Holdings plc via: www.investormeetcompany.com

Investors who already follow OCTP on the Investor Meet Company platform will automatically receive an invitation to the event.

Shares & AJ Bell Investor Evening: Wednesday 23 February 2022

John Lucas, CEO, will be presenting at the Shares and AJ Bell investor evening webinar on Wednesday 23 February 2022, covering the Company's half year results and future prospects. Participants will have the chance to ask questions online after the presentation.

Existing and potential shareholders can register to join the webinar for free via: https://www.sharesmagazine.co.uk/events/event/shares-investor-webinar-230222